BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $481,000 | +3.0% | 5,700 | -2.1% | 0.04% | +15.2% |
| Q4 2020 | $467,000 | -2.9% | 5,825 | -2.5% | 0.03% | -21.4% |
| Q3 2020 | $481,000 | -9.2% | 5,975 | -2.8% | 0.04% | -6.7% |
| Q2 2020 | $530,000 | +3.1% | 6,150 | -2.8% | 0.04% | -13.5% |
| Q1 2020 | $514,000 | +5.1% | 6,325 | +8.1% | 0.05% | +52.9% |
| Q4 2019 | $489,000 | -6.9% | 5,850 | -2.5% | 0.03% | -10.5% |
| Q3 2019 | $525,000 | -18.9% | 6,000 | -24.1% | 0.04% | -17.4% |
| Q2 2019 | $647,000 | -3.0% | 7,900 | -3.7% | 0.05% | -4.2% |
| Q1 2019 | $667,000 | +23.5% | 8,200 | 0.0% | 0.05% | -2.0% |
| Q4 2018 | $540,000 | -14.6% | 8,200 | 0.0% | 0.05% | +2.1% |
| Q3 2018 | $632,000 | +3.1% | 8,200 | -1.2% | 0.05% | 0.0% |
| Q2 2018 | $613,000 | +10.8% | 8,300 | -2.4% | 0.05% | +4.3% |
| Q1 2018 | $553,000 | -7.1% | 8,500 | -7.6% | 0.05% | -11.5% |
| Q4 2017 | $595,000 | -52.6% | 9,200 | -54.0% | 0.05% | -3.7% |
| Q3 2017 | $1,254,000 | +102.9% | 20,000 | +96.1% | 0.05% | 0.0% |
| Q2 2017 | $618,000 | +16.8% | 10,200 | 0.0% | 0.05% | +3.8% |
| Q1 2017 | $529,000 | – | 10,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |